Daily News

  • TechMed sub-track gives a close-up look at how supercomputing can revolutionize medicine

    TechMed sub-track gives a close-up look at how supercomputing can revolutionize medicine

    Advances in supercomputing to analyze big data and the role of virtual reality (VR) in pain management highlight this year’s TechMed sub-track. On Tuesday, Nov. 7, the chief medical officer […]

  • Networking Opportunities

    Networking Opportunities

    The ACR/ARHP Annual Meeting has many great opportunities to network with colleagues and others in the field. Here are a few ways to connect during the Annual Meeting. Opening Reception: […]

  • Annual Meeting offers multiple opportunities to earn MOC points

    Annual Meeting offers multiple opportunities to earn MOC points

    Attendees of Friday’s half-day, pre-meeting course, 2017 MOC Annual Meeting Course — ABIM 2017 Update in Rheumatology, will get an in-depth review of a medical knowledge module developed by the American […]

  • My Town: Resident Rheumatologists Share Their Favorites

    My Town: Resident Rheumatologists Share Their Favorites

    Arnold Ceponis, MD, PhD, Associate Clinical Professor, Rheumatology Training Program Director, University of California, San Diego, Division of Rheumatology, Allergy & Immunology, and Tania L. Rivera, MD, of the Rheumatology Center of San Diego, shared some of their favorite places to take visitors to San…

  • Thieves’ Market showcases tricky clinical cases

    Thieves’ Market showcases tricky clinical cases

    The annual ‘Thieves’ Market: Show Me Your Best Cases’ features a series of mysterious clinical cases pertaining to rheumatology. Physicians this year shared their stories of patients experiencing symptoms ranging from loose teeth to pale hands to an increased stroke risk.

  • Experts debate wisdom of tapering bDMARDs in patients with LDA

    Experts debate wisdom of tapering bDMARDs in patients with LDA

    This year’s Great Debate focused on the value of tapering biologic DMARDs (bDMARDs) in patients with rheumatoid arthritis who have achieved low disease activity (LDA).

  • IL-1 antagonists may have role in cancer fight

    IL-1 antagonists may have role in cancer fight

    Anakinra, an interleukin antagonist commonly used in the treatment of rheumatoid arthritis, is also used for other inflammatory diseases and recently has been studied as a treatment with chemotherapy for some cancers, according to Charles Dinarello, MD, who presented the Rheumatology Research Foundation Philip Hench,…

  • Gluck lecture examines crisis in osteoporosis care

    Gluck lecture examines crisis in osteoporosis care

    “A big part of the crisis has to do with how we use bisphosphonates safely and effectively,” said Kenneth G. Saag, MD, MSc, the Jane Knight Lowe Professor and Vice Chair of Medicine and Director of the Center for Outcomes, Effectiveness Research, and Education at…

  • It’s a 3-peat for The Hawkeyes

    It’s a 3-peat for The Hawkeyes

    Make it three Knowledge Bowl championships in three years for The Hawkeyes from the University of Iowa.

  • NIH plan helps investigators get an early career boost

    NIH plan helps investigators get an early career boost

    “We have a specific commitment to the next generation of clinician scientists,” said Stephen I. Katz, MD, PhD, Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of NIH.